www.fdanews.com/articles/161470-actavis-gets-complete-response-letter-for-transdermal-contraceptive-patch

Actavis Gets Complete Response Letter for Transdermal Contraceptive Patch

January 3, 2014

Actavis’ NDA for a progestin-only transdermal contraceptive patch has been turned down by the FDA, according to the company. The rejection comes about 10 months after the NDA was filed.
Drug Daily Bulletin